MLN0264, an investigational antiguanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) malignancies: Phase I study.
Cristina Cruz Zambrano
No relevant relationships to disclose
Khaldoun Almhanna
No relevant relationships to disclose
Wells A. Messersmith
Research Funding - Takeda
Jordi Rodon Ahnert
No relevant relationships to disclose
David P. Ryan
No relevant relationships to disclose
Jason Edward Faris
No relevant relationships to disclose
JungAh Jung
Employment or Leadership Position - Takeda
Adedigbo Fasanmade
Employment or Leadership Position - Takeda
Tim Wyant
Employment or Leadership Position - Takeda
Thea Kalebic
Employment or Leadership Position - Takeda
Stock Ownership - Takeda